Werewolf Therapeutics Stock Forward View - Price Action Indicator
| HOWL Stock | USD 0.66 0.06 8.33% |
Werewolf Stock outlook is based on your current time horizon. Although Werewolf Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Werewolf Therapeutics' systematic risk associated with finding meaningful patterns of Werewolf Therapeutics fundamentals over time.
As of now, the RSI of Werewolf Therapeutics' share price is approaching 41. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Werewolf Therapeutics, making its price go up or down. Momentum 41
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.41) | EPS Estimate Current Year (1.48) | EPS Estimate Next Year (1.25) | Wall Street Target Price 5.2 | EPS Estimate Current Quarter (0.38) |
Using Werewolf Therapeutics hype-based prediction, you can estimate the value of Werewolf Therapeutics from the perspective of Werewolf Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Werewolf Therapeutics using Werewolf Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Werewolf using crowd psychology based on the activity and movement of Werewolf Therapeutics' stock price.
Werewolf Therapeutics Implied Volatility | 2.15 |
Werewolf Therapeutics' implied volatility exposes the market's sentiment of Werewolf Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Werewolf Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Werewolf Therapeutics stock will not fluctuate a lot when Werewolf Therapeutics' options are near their expiration.
Werewolf Therapeutics after-hype prediction price | USD 0.66 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Werewolf Therapeutics to cross-verify your projections. Open Interest Against 2026-04-17 Werewolf Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Werewolf Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Werewolf Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Werewolf Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Werewolf Therapeutics' open interest, investors have to compare it to Werewolf Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Werewolf Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Werewolf. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Werewolf Therapeutics Additional Predictive Modules
Most predictive techniques to examine Werewolf price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Werewolf using various technical indicators. When you analyze Werewolf charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.08) | (0.07) |
| Check Werewolf Therapeutics Volatility | Backtest Werewolf Therapeutics | Information Ratio |
Werewolf Therapeutics Trading Date Momentum
| On February 02 2026 Werewolf Therapeutics was traded for 0.66 at the closing time. The top price for the day was 0.75 and the lowest listed price was 0.66 . There was no trading activity during the period 0.0. Lack of trading volume on February 2, 2026 had no short-term effect on price fluctuation. The trading price change against the current closing price is 10.61% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Werewolf Therapeutics to competition |
Other Forecasting Options for Werewolf Therapeutics
For every potential investor in Werewolf, whether a beginner or expert, Werewolf Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Werewolf Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Werewolf. Basic forecasting techniques help filter out the noise by identifying Werewolf Therapeutics' price trends.Werewolf Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Werewolf Therapeutics stock to make a market-neutral strategy. Peer analysis of Werewolf Therapeutics could also be used in its relative valuation, which is a method of valuing Werewolf Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Werewolf Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Werewolf Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Werewolf Therapeutics shares will generate the highest return on investment. By undertsting and applying Werewolf Therapeutics stock market strength indicators, traders can identify Werewolf Therapeutics entry and exit signals to maximize returns.
Werewolf Therapeutics Risk Indicators
The analysis of Werewolf Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Werewolf Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting werewolf stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.7 | |||
| Standard Deviation | 7.21 | |||
| Variance | 51.97 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Werewolf Therapeutics
The number of cover stories for Werewolf Therapeutics depends on current market conditions and Werewolf Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Werewolf Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Werewolf Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Werewolf Therapeutics Short Properties
Werewolf Therapeutics' future price predictability will typically decrease when Werewolf Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Werewolf Therapeutics often depends not only on the future outlook of the potential Werewolf Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Werewolf Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 43.9 M | |
| Cash And Short Term Investments | 111 M |
Check out Historical Fundamental Analysis of Werewolf Therapeutics to cross-verify your projections. For more information on how to buy Werewolf Stock please use our How to buy in Werewolf Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Werewolf Therapeutics. Market participants price Werewolf higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Werewolf Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Werewolf Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Werewolf Therapeutics' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Werewolf Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Werewolf Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Werewolf Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Werewolf Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.